Literature DB >> 3494742

Phenotypical and functional analysis of B lymphocytes of two siblings with combined immunodeficiency and defective expression of major histocompatibility complex (MHC) class II antigens on mononuclear cells.

G T Rijkers, J J Roord, F Koning, W Kuis, B J Zegers.   

Abstract

Phenotypic and functional analysis of B lymphocytes in two siblings with combined immunodeficiency associated with defective expression of class I and class II major histocompatibility complex (MHC) antigens on mononuclear cells is described. The results of the analysis of the membrane phenotype of the B cells performed at the age of 1 and 5 years, respectively, by the use of monoclonal antibodies against class I (HLA-A, -B, -C) and class II (HLA-DR, -DP, -DQ) MHC antigens showed a decreased expression of class I antigens and a complete lack of class II antigens. Class I antigen expression consistently remained of the same magnitude during follow-up. Class II antigen expression remarkably had been positive early in life on B cells and activated T cells, whereas monocytes were negative for class II from birth onward. B lymphocytes of both patients responded in vitro to polyclonal activation with Staphylococcus aureus Cowan I staphylococci (SAC) with the production of IgM-type immunoglobulins only. This neonatal type of response was in agreement with the membrane immunoglobulin phenotype of the B cells since a high sIgM/sIgD ratio characteristic of neonatal B cells was present. However, the expression of the FMC7 antigen on B cells of both patients was comparable to that on B cells of normal adults. We hypothesized that the lack of MHC antigen expression may impose a resting state on the lymphocytes in these patients due to ineffective cellular interactions. In this view the high sIgM/sIgD ratio reflects the activation state of the B cells rather than the maturational state of the cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494742     DOI: 10.1007/BF00916003

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  18 in total

1.  Genotyping with DNA probes in combined immunodeficiency syndrome with defective expression of HLA.

Authors:  A Marcadet; D Cohen; J Dausset; A Fischer; A Durandy; C Griscelli
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

Review 2.  Enzyme-immunoassay.

Authors:  A H Schuurs; B K Van Weemen
Journal:  Clin Chim Acta       Date:  1977-11-15       Impact factor: 3.786

3.  Maturation of human B lymphocytes--studies with a panel of monoclonal antibodies against membrane antigens.

Authors:  H Zola; P J McNamara; H A Moore; I J Smart; D A Brooks; I G Beckman; J Bradley
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

4.  Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.

Authors:  N Rebai; B Malissen; M Pierres; R S Accolla; G Corte; C Mawas
Journal:  Eur J Immunol       Date:  1983-02       Impact factor: 5.532

5.  Defective expression of mononuclear cell membrane HLA antigens associated with combined immunodeficiency: impaired cellular interactions.

Authors:  B J Zegers; C J Heijnen; J J Roord; W Kuis; R K Schuurman; J W Stoop; R E Ballieux
Journal:  Birth Defects Orig Artic Ser       Date:  1983

6.  Placental diagnosis of the "bare lymphocyte" syndrome.

Authors:  H J Schuurman; J Huber; B J Zegers; J J Roord
Journal:  N Engl J Med       Date:  1985-09-19       Impact factor: 91.245

7.  Combined immunodeficiency disease associated with absence of cell-surface HLA-A and -B antigens.

Authors:  J L Touraine; H Betuel; G Souillet; M Jeune
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

8.  A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome.

Authors:  B Lisowska-Grospierre; D J Charron; C de Préval; A Durandy; C Griscelli; B Mach
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  Detection of a novel human class II HLA antigen.

Authors:  A J Watson; R DeMars; I S Trowbridge; F H Bach
Journal:  Nature       Date:  1983 Jul 28-Aug 3       Impact factor: 49.962

10.  A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes.

Authors:  C de Préval; B Lisowska-Grospierre; M Loche; C Griscelli; B Mach
Journal:  Nature       Date:  1985 Nov 21-27       Impact factor: 49.962

View more
  10 in total

Review 1.  Genetics of HLA class II regulation.

Authors:  C R Hume; J S Lee
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  Interferon-induced expression of class II major histocompatibility antigens in the major histocompatibility complex (MHC) class II deficiency syndrome.

Authors:  S Plaeger-Marshall; A Haas; L T Clement; J V Giorgi; I S Chen; S G Quan; R A Gatti; E R Stiehm
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

3.  Activation of genetically major histocompatibility complex (MHC) class II-deficient B lymphocytes.

Authors:  A Durandy; M Mangeney; C Griscelli; M Forveille; F Le Deist; A Fischer
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

4.  Bare lymphocyte syndrome. Consequences of absent class II major histocompatibility antigen expression for B lymphocyte differentiation and function.

Authors:  L T Clement; S Plaeger-Marshall; A Haas; A Saxon; A M Martin
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  Abnormal differentiation of immunoregulatory T-lymphocyte subpopulations in the major histocompatibility complex (MHC) class II antigen deficiency syndrome.

Authors:  L T Clement; J V Giorgi; S Plaeger-Marshall; A Haas; E R Stiehm; A M Martin
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

6.  Definition of a novel complementation group in MHC class II deficiency.

Authors:  A Peijnenburg; B Godthelp; A van Boxel-Dezaire; P J van den Elsen
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

7.  Bare lymphocyte syndrome--combined immunodeficiency and neutrophil dysfunction.

Authors:  N Will; R A Seger; C Betzler; G Dockter; N Graf; M Büttner; C Irlé; J M Tiercy; F C Sitzmann
Journal:  Eur J Pediatr       Date:  1990-07       Impact factor: 3.183

8.  Autoimmune haemolytic anaemia in a child with MHC class II deficiency.

Authors:  G Horneff; R C Seitz; V Stephan; V Wahn
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

Review 9.  Pneumococcal vaccination and revaccination of older adults.

Authors:  Andrew S Artz; William B Ershler; Dan L Longo
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

10.  Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines.

Authors:  Z Yang; R S Accolla; D Pious; B J Zegers; J L Strominger
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.